With the many talents from Neurosurgery Department at Beijing Tiantan Hospital and other famous hospitals, Beijing Puhua International Hospital (BPIH) has formed a group of excellent specialists with solid techniques in neurosurgery. Through this medical platform, patients are able to choose from doctors Tiantan Hospital or organize a consultation of doctors from other first-class hospitals. There are many specialized medical groups within Neurosurgery Department, and each group often focuses only on one disease or technique. By cooperation between those specialized medical groups, patients receive the most effective and elegant care. Neurosurgery is a branch of Surgery closely related to neurology. Based on tested and reliable surgical methods, neurosurgery applies medical research to the problems of the human nervous system (brain, peripheral nervous system, and spinal cord) In addition, neurosurgery treats injury, inflammation or functional diseases of related tissues (such as the skull, spine, scalp and the cerebrovascular system). This specialty also studies the pathogenesis and treatment for diseases such as: epilepsy/seizure disorders, Parkinson disease and neuralgia. Neurosurgery is an innovative discipline in terms of diagnosis, treatment and prevention of neurological diseases. Neurosurgery treats neurological conditions including: diseases of brain, spinal cord, and peripheral nervous system. Brain Diseases: ——brain tumors (such as: glioma, meningioma, nerve sheath tumor, pituitary tumor, and skull neoplasms) ——cerebrovascular diseases (including: intracranial aneurysm, arteriovenous malformation and cavernous hemangioma) ——functional diseases (surgery for epilepsy and extrapyramidal diseases) ——congenital diseases (hydrocephalus, atelencephalia) ——brain damage (cerebral contusion/laceration, hematoma, skull fracture) spinal cord diseases: ——intra-spinal tumor, cervical spondylosis, lumbar disc herniation, spinal cord injury peripheral nervous system diseases: ——peripheral nervous system neoplasm, neural transplantation hereditary tumors: ——such as angioreticuloma (hemangioblastoma), multiple neurofibromata Treatments: ——Surgery Surgery is the often the most effective treatment for most benign and malignant tumors, brain damage and cerebrovascular malformation. ——Radiotherapy The goal of radiotherapy is to cure brain tumor, or slow down its progression. ——Chemotherapy Chemotherapy is the treatment of tumors with specific chemicals/drugs. It is usually used for cancers, and occasionally for some benign tumors. By close cooperation with the world’s top drug research and development institutions, BPIH is able to provide highly advanced chemotherapy to its patients. Specialists: ——Patients will be treated by the finest neurosurgery specialists in Asia. There are more than 90 neurosurgery specialists and 9 specialized medical groups in Tiantan Hospital, where more than 4,200 neurosurgeries are performed each year.
Dr.Xiaodi Han

Dr. Han is Chief Surgeon, Professor, Doctoral Advisor, Chief Scientist of Targeted Therapy of Glioma, Director of the Neurosurgical Department, Reviewer of Journal of Neuroscience Research, Member of Evaluation Committee of Natural Science Foundation of China (NSFC). Dr. Xiaodi Han graduated from Shanghai Medical University (now merged with Fudan University) in 1992. In the same year, he came to work at the Neurosurgery Department of Beijing Tiantan Hospital. There, he studied under Professor Jizhong Zhao, and participated in many important research projects of Beijing. He is also the editor of many neurosurgery books. Since working at the Neurosurgery Department of Beijing Tiantan Hospital, he was in charge of comprehensive treatment of glioma and various kinds of neurosurgical treatments. He has worked at Alfred Hospital, Melbourne, Australia, and Wichita State University, Kansas, America. Subsequently, he has worked at the Neurosurgery Department of University of Rochester Medical Center where he was responsible for post-graduate research specializing in stem cell treatment. Currently, Dr. Xiaodi Han is the Chief Neurosurgeon of Beijing Puhua International Hospital. He devotes himself to clinical work and teaching research of stem cell treatment for neurosurgical diseases. He is ingenious at surgical treatment and comprehensive postoperative treatment for glioma, which has brought him international recognition. In addition, he is a forerunner of stem cell targeted therapy of glioma research, both at home and overseas. Areas of specialization: Meningeoma, hypophysoma, glioma, craniopharyngioma, surgical treatment for glioma, immunological treatment for glioma, comprehensive postoperative treatment for glioma and neural stem cell treatment for spinal cord injury.